The new owner of Adaptimmune's T-cell treatment for a rare form of cancer is expected to offer jobs to most of the 160 people who still work for Adaptimmune in South Philadelphia.

Renowned Penn scientist Carl June and Jeff Marrazzo, founding CEO of Philly's Spark Therapeutics, are part of the leadership that the company that has raised $216 million from investors.

The Hospital of the University of Pennsylvania is among the 63 Pennsylvania hospitals participating in the state's Good Food, Healthy Hospitals initiative to promote healthier food options.

The costs of fossil fuel dependence are everywhere in Philadelphia. What once powered prosperity now poisons the people left behind.

Erie, Pa.'s grapes and vineyards may soon be in peril if the lanternfly reaches the county. Here's how scientists are trying to control it, including research into a parasitic wasp.